A Recombinant Chimera Vaccine Composed of LTB and <i>Mycoplasma hyopneumoniae</i> Antigens P97R1, mhp390 and P46 Elicits Cellular Immunologic Response in Mice.

Vaccines (Basel) · 2023 · PMC10457768 · PMID 37631860

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A p -value < 0.05 was considered significant, while a p -value < 0.01 was considered highly significant. 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.